Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial Proceeding/Conference:Journal of Hepatology | 2019 | 70 | ||
2018 | 54 | |||
Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B Proceeding/Conference:Journal of Hepatology | 2018 | 41 | ||
2018 | 29 | |||
Inarigivir: a novel RIG-I agonist for chronic hepatitis B Proceeding/Conference:Hepatology International | 2018 | 83 | ||
Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology | 2017 | 40 | ||
2017 | 49 |